2025.06.30
Notice of Board of Directors Appointments
June 30, 2025
J-Pharma Co., Ltd.
J-Pharma Co., Ltd. announces that the following appointments of directors have been resolved at the Ordinary General Meeting of Shareholders held on June 30, 2025, and the subsequent Board of Directors meeting.
New Board of Directors (as of June 30, 2025)
| Title | Name | |
| Representative Director & President/ CEO | Masuhiro Yoshitake | Re-appointed |
| Representative Director (Co-CEO) | Kenichi Masuya | Re-appointed |
| Director & Chief Financial Officer (CFO) | Yutaka Fujimoto | Re-appointed |
| External Director | Yasuo Miura | New |
| External Director | Sadashi Suzuki | Re-appointed |
| External Director | Shinichiro Komoto | Re-appointed |
| External Director | Kazunobu Nishimura | Re-appointed |
| External Director | Takuma Tsuzuku | Re-appointed |
| External Director, Audit & Supervisory Committee | Toshiyuki Mori | Re-appointed |
| External Director, Audit & Supervisory Committee | Teruhisa Tajima | Re-appointed |
| External Director, Audit & Supervisory Committee | Kosaku Kawaguchi | Re-appointed |
● Mr. Yasuo Miura joined Shimadzu Corporation in 1980. He served in various leadership roles, including Head of Corporate Strategy and President of the company’s European subsidiary. In 2013, he was appointed as a director of the company, concurrently holding successive Executive Officer positions, including leadership of Sales, Finance and Risk Management, as well as serving as Chief Financial Officer (CFO). He retired from these positions in March 2023. He is currently serving as an Executive Advisor to the company.
With the appointment of Mr. Yasuo Miura as External Director, the Company will further strengthen its corporate governance, accelerate global expansion, and enhance its corporate value.
Inquiries:
J-Pharma Co., Ltd.
Administration Department Public Relations
TEL: +81-3-6432-4270
https://www.j-pharma.com/en/contact
